...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Кардиология >Attitude of district internists to the problem of secondary prevention of ischemic heart disease (results of a special questionnaire survey)
【24h】

Attitude of district internists to the problem of secondary prevention of ischemic heart disease (results of a special questionnaire survey)

机译：区内专家科对缺血性心脏病二次预防问题的态度（特殊问卷调查结果）

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Attitude of district internists to the realization of a concept of secondary prevention (SP) of ischemic heart disease was studied in one of large cities in Russia. Among preparations most necessary for SP the following were named: b-blockers (79.5%), angiotensin converting enzyme inhibitors (49.3%), antiaggregants (43.8%), hypolipidemic drugs (13.7%), nitrates (63%), biologically active supplements, phyto-preparations, metabolic drugs, and glycosides (3-5% each). However actually prescribed drugs were b-blockers (100%), nitrates (96%), angiotensin converting enzyme inhibitors (89%), calcium antagonists (87%), antiaggregants (83%), cardiac glycosides (66%), vitamins (39%). Average doses of drugs were low: 21.7, 47.4 and 35.5% of possible maximal doses for statins, angiotensin converting enzyme inhibitors, and beta-blockers, respectively. Nondrug measures were used "rarely" and "often" by 26 and 74% of physicians, respectively. Only 18% of physicians directed their patients to corresponding specialists.Recommendations were mostly formal, without explanation of goals, methods and specific features of recommended measures. Moreover their prescription by physician was determined largely by subjective factors: availability of sufficient time (50%), cultural level of a patient (79%), patient's own initiative (33%), physician's personal attitude to a patient (21%).
机译：在俄罗斯大城市中研究了地区内科人士对缺血性心脏病的二级预防概念（SP）的态度。在SP最需要的制剂中，以下命名为：B阻滞剂（79.5％），血管紧张素转化酶抑制剂（49.3％），抗赤化剂（43.8％），低血脂药物（13.7％），硝酸盐（63％），生物活性补充剂，植物制剂，代谢药物和糖苷（每种3-5％）。然而，实际规定的药物是B阻滞剂（100％），硝酸盐（96％），血管紧张素转化酶抑制剂（89％），钙拮抗剂（87％），抗凝胶（83％），心糖苷（66％），维生素（ 39％）。平均药物剂量低：21.7,47.4和35.5％的他汀类药物，血管紧张素转换酶抑制剂和β-嵌体的可能最大剂量。非标度措施分别使用“很少”，“往往”分别为26％和74％的医生。只有18％的医生将患者指向相应的专家。传销主要是正式的，而不解释建议措施的目标，方法和具体特征。此外，由于医师的处方主要由主观因素确定：可用时间（50％），患者的文化水平（79％），患者自己的倡议（33％），医生对患者的个人态度（21％）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号